The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
Junyu Xue(Sun Yat-sen University), Haipeng Xiao(Sun Yat-sen University), Mengke Chen(Sun Yat-sen University), Rengyun Liu(Sun Yat-sen University), Yanbing Li(Sun Yat-sen University), Shiyong Li(Sun Yat-sen University), Shuang Yu(Heilongjiang University of Chinese Medicine), Peijie Shi(Sun Yat-sen University), Shubin Hong(Sun Yat-sen University)
Cited by 12
Related Papers
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
|Nature Communications|2018|179
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
|Journal of Clinical Investigation|2010|165
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence
|JAMA Surgery|2021|116
METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
|Molecular Therapy|2021|108